1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708
2. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 update. Eur Urol. 2022;82(4):399–410. https://doi.org/10.1016/j.eururo.2022.03.006
3. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, et al. The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 2018;23(1):313–26 e5.
4. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33–41. https://doi.org/10.1111/j.1464-410X.2004.04897.x
5. Metwalli AR, Linehan WM. Nephron-sparing surgery for multifocal and hereditary renal tumors. Curr Opin Urol. 2014;24(5):466–73. https://doi.org/10.1097/MOU.0000000000000094
6. Janssen MWW, Linxweiler J, Philipps I, Butow Z, Siemer S, Stockle M, et al. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery. World J Surg Oncol. 2018;16(1):35. https://doi.org/10.1186/s12957-018-1338-1
7. Crafa F, Rossetti ARR, Striano A, Baiamonte M, Esposito F. Ex vivo nephron-sparing surgery and kidney autotransplantation for renal tumors. J Surg Case Rep. 2021;2021(2):rjab004. https://doi.org/10.1093/jscr/rjab004
8. Russo P. Renal cell carcinoma: Presentation, staging, and surgical treatment. Semin Oncol. 2000;27(2):160–76.
9. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol. 2007;178(4 Pt 1):1189–95; discussion 95. https://doi.org/10.1016/j.juro.2007.05.134
10. Haidar GM, Hicks TD, El-Sayed HF, Davies MG. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. J Vasc Surg Venous Lymphat Disord. 2017;5(3):430–6. https://doi.org/10.1016/j.jvsv.2016.12.011
11. Gu L, Peng C, Li H, Jia T, Chen X, Wang H, et al. Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2024;196:104316. https://doi.org/10.1016/j.critrevonc.2024.104316
12. Cai W, Huang J, Yuan Y, Hu X, Li M, Kong W, et al. Sunitinib or sorafenib as neoadjuvant therapy may not improve the survival outcomes of renal cell carcinoma with tumor thrombus. Urol Int. 2018;101(4):391–9. https://doi.org/10.1159/000492723
13. Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, et al. Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther. 2015;16(5):657–61. https://doi.org/10.1080/15384047.2015.1026506
14. Novick AC, Jackson CL, Straffon RA. The role of renal autotransplantation in complex urological reconstruction. J Urol. 1990;143(3):452–7. https://doi.org/10.1016/S0022-5347(17)39988-3
15. Artiles Medina A, Gomez Dos Santos V, Diez Nicolas V, Hevia Palacios V, Ruiz Hernandez M, Laso Garcia I, et al. Kidney autotransplantation and orthotopic kidney transplantation: Two different approaches for complex cases. Adv Urol. 2022;2022:9299397. https://doi.org/10.1155/2022/9299397